ArticleBreast cancer (Tokyo, Japan)2026
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.
Nazan Demir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.